SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL LEAVE-IN SOOTHING TREATMENT- salicylic acid solution 
J. Strickland and Co.

----------

Sulfur 8 Scalp Therapy Medicated Dandruff Control Leave-In Soothing Treatment

Active Ingredient

Salicylic Acid, 2%

Purpose

Antidandruff, Seborrheic Dermatitis, Psoriasis

Use:

for relief of scalp itching, irritation, redness, scaling and flaking associated with dandruff, seborrheic dermatitis, psoriasis.

Warnings

For external use only

Ask a doctor before use

if the condition covers a large area of the body.

When using this product

avoid contact with eyes. If contact, rinse eyes thoroughly with water.

Stop use and consult a doctor if

condition worsens or does not improve after regular use of this product as directed.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Keep away from heat and open flame. Flammable

Directions

Apply to the affected area one to four times daily or as directed by a doctor. Use after shampooing or between shampoos.

Inactive Ingredients

Water, SD Alcohol 40, Propylene Glycol, Benzyl Alcohol, Menthol, Fragrance

Package Labeling:

Outer PackageInner Package

SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL LEAVE-IN SOOTHING TREATMENT 
salicylic acid solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:12022-033
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID30 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
MENTHOL (UNII: L7T10EIP3A)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:12022-033-001 in 1 BOX01/01/2020
174 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM03201/01/2020
Labeler - J. Strickland and Co. (007023112)

Revised: 10/2023
Document Id: 0834f4b7-cad7-182f-e063-6294a90a7faa
Set id: 96b24a6f-3d6e-6d60-e053-2a95a90a8330
Version: 3
Effective Time: 20231021
 
J. Strickland and Co.